Stem Cells In Wound Healing With Collagen Matrix as a Carrier
Wounds
About this trial
This is an interventional treatment trial for Wounds focused on measuring wounds, stem cells, collagen matrix, maturation
Eligibility Criteria
Inclusion Criteria:
- Patients with an acute or chronic would that present for a plastic surgery consultation for wound care.
Exclusion Criteria:
- Active Smokers,
- Immunosuppressed patients,
- nutritionally depleted patients,
- terminally ill cancer patients,
- transplant patients,
- ASA class IV and higher will be excluded
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Standard Treatment
Amniotic Stem Cells and Collagen Matrix
Patients in the Control Arm will receive collagen matrix for wound coverage and standard wound care that will include chemical/surgical debridement (using a topical paste to clean the wound or removing bad tissue using a scalpel or scissors) and dressing care. In addition, they may also have imaging studies (such as x-ray, CAT scan, ultrasound) performed if determined to be necessary by the physician.
Patients will receive amniotic stem cells(NuCel) embedded in collagen matrix for wound coverage, and standard wound care that will include chemical/surgical debridement (using a topical paste to clean the wound or removing bad tissue using a scalpel or scissors) and dressing care. In addition, they may also have imaging studies (such as x-ray, CAT scan, ultrasound) performed if determined to be necessary by the physician.